Biotech New GBT Multinational Survey Shines a Needed Light on the Misunderstood Realities, Unseen Burden and Care Challenges of Sickle Cell Disease June 13, 2022
Food & Beverage GURU Organic Energy Launches Bold, Courageously Real and Largest National Marketing Campaign to Date June 13, 2022
Biotech Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma June 12, 2022
Crypto InvestmentPitch Media Video Discusses LUXXFOLIO’s Strategic Investment from BIGG Digital Assets Inc. June 10, 2022
Health Fulcrum Therapeutics Announces Proof-of-Concept for FTX-6058 in Sickle Cell Disease Based on Initial Data from the Ongoing Phase 1b Trial June 10, 2022
Health Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl) June 10, 2022
Health Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 10, 2022
Real Estate Bluerock Residential Growth REIT (BRG) Announces Second Quarter Dividends on Common Stock, 7.625% Series C Cumulative Redeemable Preferred Stock, and 7.125% Series D Cumulative Preferred Stock, and June Dividends on Series B Preferred Stock and Series T Preferred Stock June 10, 2022